Products/Services Used | Details | Operation |
---|---|---|
Catalog Antibody> | The following TLR ligands and inhibitors were obtained from InvivoGen (San Diego, CA, USA): CpG (2 mM), Pam3C (300 ng/mL), PolyI:C(10mg/mL),CLI-095(1mM),andBX795(100nM).LPS(500ng/mL)wasobtainedfromSigma.HMGB1(1mg/mL)wasobtained from GenScript (Piscataway, NJ, USA). | Get A Quote |
Tumors contain hostile inflammatory signals generated by aberrant proliferation, necrosis, and hypoxia. These signals are sensed and acted upon acutely by the Toll-like receptors (TLRs) to halt proliferation and activate an immune response. Despite the presence of TLR ligands within the microenvironment, tumors progress, and the mechanisms that permit this growth remain largely unknown. We report that self-renewing cancer stem cells (CSCs) in glioblastoma have low TLR4 expression that allows them to survive by disregarding inflammatory signals. Non-CSCs express high levels of TLR4 and respond to ligands. TLR4 signaling suppresses CSC properties by reducing retinoblastoma binding protein 5 (RBBP5), whi... More